These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 9460083

  • 1. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat.
    Yu XQ, Nikolic-Paterson DJ, Mu W, Giachelli CM, Atkins RC, Johnson RJ, Lan HY.
    Proc Assoc Am Physicians; 1998; 110(1):50-64. PubMed ID: 9460083
    [Abstract] [Full Text] [Related]

  • 2. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM, Ng YY, Lin SL, Chiang WC, Lan HY, Tsai TJ.
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat.
    Yu XQ, Fan JM, Nikolic-Paterson DJ, Yang N, Mu W, Pichler R, Johnson RJ, Atkins RC, Lan HY.
    Am J Pathol; 1999 Mar; 154(3):833-41. PubMed ID: 10079261
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity.
    Tipping PG, Huang XR, Berndt MC, Holdsworth SR.
    Eur J Immunol; 1996 Feb; 26(2):454-60. PubMed ID: 8617318
    [Abstract] [Full Text] [Related]

  • 7. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D, Nazneen A, Taguchi T, Razzaque MS.
    Am J Nephrol; 2008 Feb; 28(4):555-68. PubMed ID: 18239382
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N.
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [Abstract] [Full Text] [Related]

  • 9. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
    Lan HY, Bacher M, Yang N, Mu W, Nikolic-Paterson DJ, Metz C, Meinhardt A, Bucala R, Atkins RC.
    J Exp Med; 1997 Apr 21; 185(8):1455-65. PubMed ID: 9126926
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis.
    Timoshanko JR, Kitching AR, Semple TJ, Holdsworth SR, Tipping PG.
    J Am Soc Nephrol; 2005 Sep 21; 16(9):2646-56. PubMed ID: 16033860
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.
    Shimizu A, Masuda Y, Mori T, Kitamura H, Ishizaki M, Sugisaki Y, Fukuda Y.
    J Am Soc Nephrol; 2004 Oct 21; 15(10):2655-65. PubMed ID: 15466270
    [Abstract] [Full Text] [Related]

  • 12. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
    Kramer AB, Ricardo SD, Kelly DJ, Waanders F, van Goor H, Navis G.
    J Pathol; 2005 Dec 21; 207(4):483-92. PubMed ID: 16211543
    [Abstract] [Full Text] [Related]

  • 13. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
    Isome M, Fujinaka H, Adhikary LP, Kovalenko P, El-Shemi AG, Yoshida Y, Yaoita E, Takeishi T, Takeya M, Naito M, Suzuki H, Yamamoto T.
    Nephrol Dial Transplant; 2004 Dec 21; 19(12):2997-3004. PubMed ID: 15574997
    [Abstract] [Full Text] [Related]

  • 14. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
    Odobasic D, Kitching AR, Semple TJ, Holdsworth SR.
    J Am Soc Nephrol; 2006 Apr 21; 17(4):1044-53. PubMed ID: 16540559
    [Abstract] [Full Text] [Related]

  • 15. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
    Odobasic D, Kitching AR, Semple TJ, Timoshanko JR, Tipping PG, Holdsworth SR.
    J Am Soc Nephrol; 2005 Jul 21; 16(7):2012-22. PubMed ID: 15944341
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
    Odobasic D, Kitching AR, Semple TJ, Holdsworth SR.
    J Am Soc Nephrol; 2007 Mar 21; 18(3):760-70. PubMed ID: 17267745
    [Abstract] [Full Text] [Related]

  • 18. Tubular osteopontin expression in patients with ANCA-associated glomerulonephritis.
    Nitta K, Horita S, Okano K, Uchida K, Honda K, Koike M, Sekine S, Itabashi M, Tsukada M, Takei T, Suzuki K, Yumura W, Nihei H.
    Clin Nephrol; 2001 Dec 21; 56(6):459-66. PubMed ID: 11770797
    [Abstract] [Full Text] [Related]

  • 19. Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury.
    Allen AR, McHale J, Smith J, Cook HT, Karkar A, Haskard DO, Lobb RR, Pusey CD.
    J Immunol; 1999 May 01; 162(9):5519-27. PubMed ID: 10228033
    [Abstract] [Full Text] [Related]

  • 20. Endogenous IL-13 limits humoral responses and injury in experimental glomerulonephritis but does not regulate Th1 cell-mediated crescentic glomerulonephritis.
    Kitching AR, Turner AL, Wilson GR, Edgtton KL, Tipping PG, Holdsworth SR.
    J Am Soc Nephrol; 2004 Sep 01; 15(9):2373-82. PubMed ID: 15339986
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.